Helena Son

Helena Son

Auto-generated profile, based on publicly available information

Helena Son

Michael DeGroote School of Medicine McMaster University Hamilton Ontario Canada

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2026 in Arthroscopy
Verified
Journal Article
Open access
HSHelena Son
Helena Son
BBBenjamin Blackman
Benjamin Blackman
JDJoshua Dworsky‐Fried
Joshua Dworsky‐Fried
DCDan Cohen
Dan Cohen
YBYoan Bourgeault‐Gagnon
Yoan Bourgeault‐Gagnon
OAOlufemi Ayeni
Olufemi Ayeni
Purpose: To report conversion rates to total hip arthroplasty (THA), patient‐reported outcome measures, and complication rates in adults aged ≥ 40 years undergoing hip arthroscopy since 2016. Methods: MEDLINE, EMBASE, and PubMed were searched from January 2016 to March 2025, and pertinent data were abstracted from eligible studies according to the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines. To provide an updated synthesis without duplicating prior work, this review was limited to studies published from 2016 onward, following a previous systematic review that comprehensively evaluated outcomes of hip arthroscopy in patients aged 40 years and older through 2015. Inclusion criteria were studies involving patients aged ≥ 40 years who underwent hip arthroscopy, published in English, and reporting at least 1 patient‐reported outcome measure or clinical outcome. Exclusion criteria included studies that were not Level I, II, or III studies with nonsurgical treatments or studies with duplicate patient cohorts. Results: Six studies were included (2 Level II cohort studies, 4 Level III cohort studies), encompassing 33,091 patients (30,549 ≥ 40 years; 92.3%). Among 5 studies (n = 2479), the overall THA conversion rate in patients ≥ 40 ranged from 5% to over 21%. The 2‐year THA conversion rate ranged from 9% to 13% in patients aged 40 to 60 years, and the 5‐year conversion rate was as high as 20.2%. Five studies reporting patient‐reported outcome measures showed significant improvements that exceeded the minimal clinically important difference at a follow‐up period of 2 years. Functional outcomes (Modified Harris Hip Score, Hip Outcome Score Activity of Daily Living Scale, Hip Outcome Score Sport Scale, and Nonarthritic Hip Score) were significantly worse in patients > 45 years compared with those < 45 years. Twenty‐one procedure‐related complications occurred among 1807 hips (1.16%) in patients 40 and older, the 2 most common being superficial soft‐tissue injuries (n = 4) and transient neuropraxia/nerve palsy (n = 3). Conclusions: Although hip arthroscopy continues to display statistically and clinically significant postoperative improvements in patients aged 40 and older, the risk of conversion to THA remains substantially higher compared with younger populations. Level of Evidence: Level III, systematic review of Level II and III studies.

14 April 2026 in Journal of ISAKOS
Verified
Journal Article
Open access
HSHelena Son
Helena Son
ASAgarsh Satheesh
Agarsh Satheesh
DCDan Cohen
Dan Cohen
MBMarc Daniel Bouchard
Marc Daniel Bouchard
EMEugene Maida
Eugene Maida
OAOlufemi R. Ayeni
Olufemi R. Ayeni
The management of chronic hip pain in patients not amenable to surgical treatment remains challenging. Increasing evidence suggests that targeted denervation may reduce hip pain by disrupting nociceptive input. To synthesize available evidence on patient-level outcomes following nerve-targeted interventions for hip pain; to summarize procedural techniques, patient selection criteria, and reported clinical outcomes associated with these interventions EVIDENCE REVIEW: A comprehensive search of MEDLINE, EMBASE, and PubMed was performed following Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. Eligible studies reported pain-related or functional outcomes after nonpharmacological, nerve-targeted interventions for hip pain. Inter-reviewer agreement was assessed using the kappa (κ) statistic and study quality was appraised using Methodological Index for Non-Randomized Studies (MINORS) criteria. Descriptive statistics summarized study characteristics, patient demographics, procedural details, and outcomes. Ten studies (358 patients, 370 hips) were included (one level II, one level III, eight level IV studies). Eight studies evaluated radiofrequency ablation and two examined pericapsular alcohol neurolysis. Most interventions targeted the femoral and obturator nerves. Across studies, 60-80% of patients achieved >50% pain relief at 3-6 months, with some reporting sustained benefits to 12 months. Significant improvements were also observed in functional outcomes and reductions in opioid use were reported in some studies, although statistically significant reductions were demonstrated in only one study. Complications were rare and minor, limited to transient neuritis, hematomas, or sensory changes without lasting sequelae. and Relevance: Nerve-targeted interventions may provide meaningful short-term improvements in pain, function, and analgesic use in patients with refractory hip pain. These interventions may represent a potential therapeutic option in patients not amenable to surgical treatment or with persistent symptoms despite prior surgical management. However, the evidence base remains limited by heterogeneity and study design, highlighting the need for high-quality randomized controlled trials to establish optimal techniques and long-term effectiveness. IV, systematic review of level II, III, and IV studies.

16 August 2026 in Arthroscopy
Verified
Journal Article
Open access
PDF file
PVPrushoth Vivekanantha
Prushoth Vivekanantha
HSHelena Son
Helena Son
JKJeffrey Kay
Jeffrey Kay
SKSatyavenkata Kotipalli
Satyavenkata Kotipalli
MBMarc Daniel Bouchard
Marc Daniel Bouchard
OAOlufemi R. Ayeni
Olufemi R. Ayeni
Purpose: To assess the relation between the fragility index (FI) and reverse fragility index (RFI) with the minimum number of patients needed to reverse statistical significance (e.g. henceforth termed the lost to follow‐up index (LTFI) and reverse LTFI (R‐LTFI), respectively) and apply machine learning to identify which trial parameters are most important in FI, RFI, and continuous fragility index composition given the nonlinearity of these metrics. Methods: A total of 300,000 randomized controlled trials (100,000 for each metric) were simulated using common trial parameter value ranges. For FI and RFI, LTFI and R‐LTFI values, respectively, were calculated as the minimum number of patients lost to follow‐up to reverse significance in either direction. Machine learning models were trained to assess the relative importance of P value, sample size, and event numbers in FI and RFI composition and P value, group means, group standard deviations, and group sizes for continuous fragility index composition. Results: Among their respective cohorts of 100,000, the LTFI and R‐LTFI were greater than FI and RFI in 84.9% and 95.5% of simulated randomized controlled trials, respectively. Random Forest and XGBoost machine learning models had near perfect accuracy in modeling fragility metrics (R 2 ≥ 0.98), justifying its use over standard linear regression models in identifying trial parameters that are most important in determining fragility values. Feature importance analysis showed that the P value accounted for 79.8%, 71.9%, and 64.5% of variability in FI, RFI, and continuous fragility index values. Conclusions: Fragility metrics are primarily mathematical reflections of standard trial parameters and are heavily driven by the P value. Direct comparisons between fragility metrics and lost to follow‐up are statistically inappropriate because LTFI and R‐LTFI routinely exceed FI and RFI, respectively, and should be avoided in future fragility‐based studies. Clinical Relevance: Understanding that statistical fragility metrics are mathematical transformations of trial parameters, and not independent measures of robustness, can prevent trial misinterpretation. Additionally, recognizing that the number of patients required to be lost to follow‐up to reverse trial significance often exceeds fragility metrics should discourage inappropriate comparisons in future orthopaedic research.

18 September 2026 in Arthroscopy
Verified
Journal Article
Open access
PDF file
HSHelena Son
Helena Son
VYVincent Yu
Vincent Yu
PVPrushoth Vivekanantha
Prushoth Vivekanantha
MBMarc Daniel Bouchard
Marc Daniel Bouchard
KNKanto Nagai
Kanto Nagai
DSDarren L. De Sa
Darren L. De Sa
Purpose: To systematically review and analyze the existing literature on the use of the Forgotten Joint Score‐12 (FJS‐12) in patients undergoing anterior cruciate ligament reconstruction (ACLR), with the aim of evaluating its effectiveness as a complementary tool to traditional patient‐reported outcome measures (PROMs) in assessing postoperative outcomes. Methods: PubMed, Embase, and MEDLINE were searched on February 7, 2026. Studies were included if they used the FJS‐12 to assess patients after ACLR. The quality of included studies was appraised, and data were extracted on demographics, surgical details, and outcome measures including FJS‐12 and its correlations with other PROMs. Descriptive statistics were used to summarize the findings. Results: Thirteen studies encompassing 1295 patients and 1316 knees were included. The mean age was 31.3 years, and the mean follow‐up time was 44.3 months (range of means, 12.0‐139.0 months). FJS‐12 scores ranged widely from 37.0 to 92.6. The score showed strong, significant positive correlations with International Knee Documentation Committee subjective knee form score, Lysholm, and Knee Osteoarthritis and Outcome Score ( r > 0.80 in 3 of 4 studies reporting correlations), particularly in isolated ACLR cases. FJS‐12 showed a significant low‐to‐moderate correlation with Tegner activity levels ( r = 0.318‐0.606, P  ≤  .003) in 2 of 3 studies. Subgroup analyses suggested higher FJS‐12 scores in patients with restoration of hyperextension >5° and symmetrical range of motion to the contralateral limb. Factors such as radiographic osteoarthritis and partial meniscectomy were associated with lower FJS‐12 scores. Across studies evaluating sex‐based differences, no consistent or clinically meaningful differences in FJS‐12 scores were observed between men and women. Conclusions: The FJS‐12 is a patient‐centered PROM that complements traditional metrics by capturing the subjective experience of joint awareness after ACLR. It shows moderate‐to‐strong correlations with established ACLR PROMs, supporting construct validity, and clinically meaningful thresholds have been reported, supporting clinical interpretability; however, the magnitude of responsiveness over time cannot be fully characterized because of limited reporting of longitudinal effect sizes. Level of Evidence: Level IV, systematic review of Level II to IV studies.

30 July 2026 in Journal of Experimental Orthopaedics
Verified
Journal Article
Open access
HSHelena Son
Helena Son
ADAndjela Dragovic
Andjela Dragovic
MBMarc Daniel Bouchard
Marc Daniel Bouchard
MCMaaya Chander
Maaya Chander
PVPrushoth Vivekanantha
Prushoth Vivekanantha
AMAmit Meena
Amit Meena
Purpose: Obesity (body mass index [BMI] ≥ 30 kg/m 2 ) is increasingly prevalent among total knee arthroplasty (TKA) patients and is associated with unique challenges. The role of various TKA alignment strategies in obese patients remains unclear. To evaluate the clinical, functional, radiographic, survivorship and complication outcomes of primary TKA in obese patients across alignment philosophies. Methods: Eligible studies (1) included patients who underwent primary TKA with defined alignment, (2) reported BMI ≥ 30 kg/m 2 or provided stratified data for obese versus non‐obese groups, (3) reported at least one of: patient‐reported outcome measures (PROMs), range of motion (ROM), radiographic outcomes, or complications and (4) were randomized controlled trials (RCTs), cohort studies or case–control studies. Results: Thirty studies were included. 8468 obese patients (14,662 knees) underwent mechanically aligned TKA, with mean follow‐up of 91.1 ± 45.3 months (range, 0.5–110.5 months). Mechanically aligned TKA in obese patients was associated with post‐operative improvements in PROMs, including Knee Society Score, Western Ontario and McMaster Universities Osteoarthritis Index and Oxford Knee Score. Short‐term cumulative aseptic revision incidence was low, ranging from 0.5% to 1.3%, while revision‐free survivorship commonly exceeded 95% at short‐term and >90% at long‐term follow‐up. Radiographic outcomes demonstrated reliable restoration of near‐neutral limb alignment across BMI strata. One study evaluated a kinematically‐designed bicruciate‐stabilized implant with an unspecified alignment strategy in obese patients, and another study evaluated functional alignment in obese patients, limiting comparisons. Conclusion: Evidence evaluating the influence of alignment on outcomes in obese patients undergoing TKA remains insufficient to determine whether alignment philosophy meaningfully affects clinical or radiographic outcomes. Although mechanically aligned TKA demonstrated generally acceptable post‐operative outcomes in obese cohorts, the available literature was overwhelmingly dominated by mechanically aligned studies, with only limited evaluation of alternative approaches. Level of Evidence: Level IV.

2 November 2026 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
MAMichael Ade-Conde
Michael Ade-Conde
HSHelena Son
Helena Son
BLBrent A. Lanting
Brent A. Lanting
JHJames L. Howard
James L. Howard
HKHassaan Abdel Khalik
Hassaan Abdel Khalik